MCMedicalCodingSoftware
Z79.810

Z79.810Long term (current) use of selective estrogen receptor modulators (SERMs)

Billable / specific codeICD-10-CMPOA exempt

Z79.810 is a billable, specific ICD-10-CM code for long term (current) use of selective estrogen receptor modulators (serms). It is valid for submission on a claim.

Inclusion terms

Alternative wordings a physician may use in the chart for this same code.

  • Long term (current) use of raloxifene (Evista)
  • Long term (current) use of tamoxifen (Nolvadex)
  • Long term (current) use of toremifene (Fareston)

Excludes1 inherited from the categories above Z79.810

These are not written on Z79.810, but they bind it: a note on a category applies to every code beneath it. Billing Z79.810 with anything listed here is a denial.

Written on Z79.81 Long term (current) use of agents affecting estrogen receptors and estrogen levels

  • hormone replacement therapy (Z79.890)

Excludes2 inherited from the categories above Z79.810

Also inherited, and the opposite of Excludes1: these conditions are not part of Z79.810, but a patient can have both, so you may code both.

Written on Z79 Long term (current) drug therapy

  • drug abuse and dependence (F11-F19)
  • drug use complicating pregnancy, childbirth, and the puerperium (O99.32-)

Risk adjustment

Z79.810 does not map to an HCC and does not risk-adjust under CMS-HCC V28. That is normal — most ICD-10 codes do not. It still needs to be coded correctly; it just will not move a RAF score.

Medicare coverage

Z79.810 is named in 9 Medicare coverage policies 9 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.

  • A52370Billing and Coding: Bevacizumab and biosimilars
  • A52399Billing and Coding: Denosumab (Prolia®, Xgeva®, Jubbonti®) and biosimilars
  • A56907Billing and Coding: Bisphosphonate Drug Therapy
  • A56907Billing and Coding: Bisphosphonate Drug Therapy

How Z79.810 is indexed

Coders do not find codes by browsing the tabular list — they look them up in the alphabetic index, under the word the physician wrote. These are the index entries that lead here, so you can see which chart wordings map to Z79.810.

  • Long-termEvista
  • Long-termFareston
  • Long-termNolvadex
  • Long-termraloxifene(Evista)
  • Long-termselective estrogen receptor modulators(SERMs)
  • Long-termtamoxifen(Nolvadex)
  • Long-termtoremifene(Fareston)
  • Therapydrug, long-termEvista
  • Therapydrug, long-termFareston
  • Therapydrug, long-termNolvadex
  • Therapydrug, long-termraloxifene(Evista)
  • Therapydrug, long-termselective estrogen receptor modulators(SERMs)

Code history

Z79.810 has not changed since FY2024 — no addition, revision or deletion across the three most recent ICD-10-CM releases.

Related codes at this level

Codes that share Z79.81. If Z79.810 is not quite right, the correct code is usually one of these.

Questions about Z79.810

Is Z79.810 a billable ICD-10-CM code?
Yes. Z79.810 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
Where does Z79.810 sit in the tabular list?
Factors influencing health status and contact with health services (Z00-Z99), in the block Persons with potential health hazards related to family and personal history and certain conditions influencing health status (Z77-Z99).
What cannot be coded together with Z79.810?
Z79.810 carries Excludes1 notes, which means the conditions they list can never be coded together with it on the same encounter. Some are written on the categories above Z79.810 (Z79.81) and apply to it just the same.
ICD-10-CMFY2026-Apr· effective April 1, 2026

Loaded directly from the CMS/NCHS ICD-10-CM public-domain release — see data sources and our editorial policy. If this page disagrees with the CMS tabular list, this page is wrong. Reference information for professional coders; not medical or billing advice.